Melanoma, good results for immunotherapy that infiltrates lymphocytes

For now, the acronym, “TILs”, is known only to those specialists who are also involved in cancer research. The acronym, from English, stands for lymphocytes that infiltrate the tumor. They are the ones on which the scientific community is working to broaden and diversify the response of patients to immunotherapy. A possible new treatment opportunity, which seems to work in patients affected by metastatic melanoma.